MT
Monocacy Therapeutics Inc.
SEC filingBiotechnology · Monrovia, MD
Amount raised$49sold at filing
Total offering$49
Investors in the raise1count reported to the SEC
FiledSep 21, 2026first sale Sep 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Suman VodnalaExecutive Officer
Shashank PatelExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.